Dana-Farber Cancer Institute Site Number : 004

Boston, Massachusetts 02215

0 studies enrolling now · 1 studies all time

What they study most

Chronic Graft-versus-host-disease

Studies at this site

• Efficacy and Safety of KD025 in Subjects With cGVHD After At Least 2 Prior Lines of Systemic Therapy — Stopped early